News Focus
News Focus
Followers 5
Posts 3223
Boards Moderated 0
Alias Born 07/07/2002

Re: marginnayan post# 395327

Wednesday, 05/25/2005 5:17:52 PM

Wednesday, May 25, 2005 5:17:52 PM

Post# of 704047
EYET - From SI - by MD

It's too bad wall street does not understand the pathophysiology of wet AMD. No drug can reverse the retinal damage of AMD. VEGF inhibitors may slow down or at best stop further damage. Vision improvement suggested in the Genentech trial is probably due to reduction in macular edema and should therefore be limited. Once the edema is reduced then no further improvement should be expected. Critical review of Genentech data and study design is needed.

----

Here goes DNA's drug claim for vision improvement


Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today